Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Beclometasone Dipropionate/Formoterol Fumarate is Similarly Effective to Budesonide/Formoterol Fumarate in Chinese Patients with COPD: The FORSYYN Double-Blind, Randomised Study.
Wen F, Wu Y, Xing C, Zhu Y, Chen Y, Mei X, Corradi M, Cappellini G, Calabro E, Amodio S, Zhu C, Galkin D. Wen F, et al. Among authors: galkin d. COPD. 2024 Dec;21(1):2425157. doi: 10.1080/15412555.2024.2425157. Epub 2024 Nov 11. COPD. 2024. PMID: 39529298 Free article. Clinical Trial.
CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD.
Govoni M, Bassi M, Girardello L, Lucci G, Rony F, Charretier R, Galkin D, Faietti ML, Pioselli B, Modafferi G, Benfeitas R, Bonatti M, Miglietta D, Clark J, Pedersen F, Kirsten AM, Beeh KM, Kornmann O, Korn S, Ludwig-Sengpiel A, Watz H. Govoni M, et al. Among authors: galkin d. Respir Res. 2024 Oct 19;25(1):380. doi: 10.1186/s12931-024-02999-5. Respir Res. 2024. PMID: 39427187 Free PMC article. Clinical Trial.
Effects of inhaled beclometasone dipropionate/formoterol fumarate/glycopyrronium vs. beclometasone dipropionate/formoterol fumarate and placebo on lung hyperinflation and exercise endurance in chronic obstructive pulmonary disease: a randomised controlled trial.
Watz H, Kirsten AM, Ludwig-Sengpiel A, Krüll M, Mroz RM, Georges G, Varoli G, Charretier R, Cortellini M, Vele A, Galkin D. Watz H, et al. Among authors: galkin d. Respir Res. 2024 Oct 17;25(1):378. doi: 10.1186/s12931-024-02993-x. Respir Res. 2024. PMID: 39420338 Free PMC article. Clinical Trial.
The effect of inhaled extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide on distal and central airway indices, assessed using Functional Respiratory Imaging in COPD (DARWiIN).
Skloot GS, Guasconi A, Lavon BR, Georges G, De Backer W, Galkin D, Cortellini M, Panni I, Bates JHT. Skloot GS, et al. Among authors: galkin d. Respir Res. 2023 Oct 6;24(1):244. doi: 10.1186/s12931-023-02549-5. Respir Res. 2023. PMID: 37803368 Free PMC article.
Clinical burden of illness among patients with severe eosinophilic COPD.
Müllerová H, Meeraus WH, Galkin DV, Albers FC, Landis SH. Müllerová H, et al. Among authors: galkin dv. Int J Chron Obstruct Pulmon Dis. 2019 Mar 28;14:741-755. doi: 10.2147/COPD.S194511. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31114180 Free PMC article.
15 results